{"id":"NCT03489941","sponsor":"Bausch & Lomb Incorporated","briefTitle":"A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and Vehicle","officialTitle":"A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and Vehicle in the Treatment of Ocular Itching Associated With Allergic Conjunctivitis as Induced by the Conjunctival Allergen Challenge Model (Ora-CAC®)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-04-07","primaryCompletion":"2018-04-29","completion":"2018-04-29","firstPosted":"2018-04-06","resultsPosted":"2021-05-17","lastUpdate":"2023-06-08"},"enrollment":65,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Allergic Conjunctivitis"],"interventions":[{"type":"DRUG","name":"EM-100","otherNames":[]},{"type":"DRUG","name":"Zaditor®","otherNames":[]},{"type":"DRUG","name":"Vehicle","otherNames":[]}],"arms":[{"label":"EM-100","type":"EXPERIMENTAL"},{"label":"Zaditor®","type":"EXPERIMENTAL"},{"label":"Vehicle","type":"EXPERIMENTAL"}],"summary":"A Single-Center study to demonstrate the non-inferiority of EM-100 to Zaditor® in the treatment of ocular itching.","primaryOutcome":{"measure":"Ocular Itching","timeFrame":"3, 5 and 7 minutes post-Conjunctival Allergen Challenge (CAC) on Day 1","effectByArm":[{"arm":"EM-100","deltaMin":0.81,"sd":0.787},{"arm":"Zaditor®","deltaMin":0.79,"sd":0.75},{"arm":"Vehicle","deltaMin":1.98,"sd":0.935}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":3},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":65},"commonTop":[]}}